Wird geladen...

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Format: Artigo
Sprache:Inglês
Veröffentlicht: Endocrinology Research Centre 2018-12-01
Schriftenreihe:Ожирение и метаболизм
Schlagworte:
Online Zugang:https://www.omet-endojournals.ru/jour/article/view/9584
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!